- (PLX AI) - Lundbeck shares fell 2% in early trading, after the company's earnings came in just below estimates, with Vyepti the biggest disappointment, analysts said.
- • Vyepti sales for the full year were DKK 492 million, a miss of 6% vs consensus
- • Seen only in the Q4 context, Vyepti sales missed by 10%
- • Lundbeck only barely delivered on its 2021 guidance, SEB said
- • The report was weak on most items, and estimates for 2022 will likely be down more than 5%, SEB said
- • Outlook for 2022 is below consensus, with revenue of DKK 16.7-17.3 billion vs consensus of DKK 17.5 billion
© 2022 PLX AI
